Rationale for an Association Between PD1 Checkpoint Inhibition and Therapeutic Vaccination Against HIV
The pathogenesis of HIV immunodeficiency is mainly dependent on the cytopatic effects exerted by the virus against infected CD4+ T cells. However, CD4+ T cell loss cannot be the only pathogenic factor since severe opportunistic infections may develop in HIV infected patients with normal CD4+ T cell...
Main Authors: | Gilberto Filaci, Daniela Fenoglio, Lucia Taramasso, Francesco Indiveri, Antonio Di Biagio |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.02447/full |
Similar Items
-
Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade
by: Carlo Genova, et al.
Published: (2022-01-01) -
Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4<sup>+</sup> T Cells
by: Reem Saleh, et al.
Published: (2019-10-01) -
Soluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapy
by: Chris Y. Chiu, et al.
Published: (2023-03-01) -
Regulatory T cells (Tregs): A major immune checkpoint to consider in combinatorial therapeutic HIV-1 vaccines
by: Audrey Hubert, et al.
Published: (2018-06-01) -
Regulatory T cells: the ultimate HIV reservoir?
by: Joseph Rocco, et al.
Published: (2018-10-01)